Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

A Promising Natural Alternative for Estrogen Deficiency
  • USA - English


News provided by

H.R. Momayez Zadeh

Apr 13, 2022, 12:20 ET

Share this article

Share toX

Share this article

Share toX

H.R. Momayez Zadeh says, currently, the estrogen deficiency in ovariohysterectomized, total oophorectomized, pre and post menopausal women is principally achieved through Hormone Therapy, which notwithstanding its adverse effects, there is insufficient evidence to assess the risk of its long-term application in perimenopausal or postmenopausal women younger than 50 years of age.

MIAMI, April 13, 2022  Menopausal Women and Women with Ovariohysterectomy or Total Oophorectomy (WMOO) do not Produce Sufficient Estrogen and Same Contributes to Cardiovascular, Neurodegenerative Diseases, as well as bone and Metabolic Issues.

There is insufficient evidence to assess the risk of hormone therapy long-term application in perimenopausal or postmenopausal women younger than 50 years of age (1).

Phytoestrogens are nonsteroidal plant compounds that possess estrogenic activity through their phenolic ring, which enables them to bind to estrogen receptors in humans and animals and could be essentially beneficial to WMOO, as well as sterilized female dogs. However there are issues with phytoestrogens, as well.

When phytoestrogen are taken in the form of food source or as supplements, their intake has been associated with adverse reporting, (2, 3, 4, 5, 6, 7).

Liquiritigenin is unique bioactive phytoestrogen, isolated from the roots of plants belonging to Radix Glycyrrhizae (licorice) and has shown a plethora of beneficial effects. (Review of studies listed under Liquiritigenin in PubMed) and recognized by US National Institutes of Health, The National Center for Advancing Translational Sciences states as having strong affinity to estrogen receptor Beta (8).

Phytoestrogens, generally, stimulate the immune system and immune stimulation is synonymous with activation of the immune system's inflammatory stimuli, which if not regulated, ultimately results in chronic inflammation and undesirable health consequences. (9,10)

Accordingly, for optimum benefits of Liquiritigenin, an anti-inflammatory is paramount to Liquiritigenin "enhancement" of immune system.
In a Randomized Controlled Trial, a mix of Flavonoid and fish oil Supplement has shown to produce only an immune enhancing effect, indicating a clinical inflammation (11).

Liquiritigenin is a Flavanoid. Additionally, when combined, the estrogen (17β-oestradiol) with Omega-3 there was a synergistic bone-protective efficacy through up-regulation of gene RUNX2, an essential transcription factor for bone formation, as well as the suppression of bone-resorbing cytokine IL-1β (12). Liquiritigenin is a receptor beta agonist.
Choline is also equally paramount to confer Liquiritigenin with an enhanced neuroprotective aspects.

In the nervous system, biological estrogen's neuroprotective effects is strongly dependent on its interactions with the cholinergic system (13).

Liquiritigenin benefits in memory and cognitive impairment is through cholinergic system with choline being the building block of the cholinergic system (14).

The mixture of Liquiritigenin, Omega-3 and Choline is a promising natural approach to estrogen deficiency.

For a more detailed description, Please click here

References:
(1) Long-term hormone therapy for perimenopausal and postmenopausal women
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143
(2) Soy allergy in perspective Current Opinion in Allergy and Clinical Immunology: June 2008 - Volume 8 - Issue 3 - p 270-27
(3) Anaphylaxis to flaxseed in a non-atopic adult patient. Annals of Allergy, Asthma & Immunology. March 25, 2022. DOI:https://doi.org/10.1016/j.anai.2022.03.023
(4) Verzele M. 100 years of hop chemistry and its relevance to brewing. J Inst Brewing 1986;92:32-48.
(5) Effects of Licorice on the Cardiovascular System Foods. 2019 Oct; 8(10): 495.
(6) The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation. Endocrinology. 2008 May;149(5):2567-75. doi: 10.1210/en.2007-1173. Epub 2008 Jan 31.
(7) The Effect of Soy Phytoestrogen. Supplementation on Thyroid Status
The Journal of Clinical Endocrinology & Metabolism, Volume 96, Issue 5, 1 May 2011, Pages 1442–1449
(8) https://drugs.ncats.io/drug/T194LKP9W6
(9) The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc Natl Acad Sci U S A. 2002 May 28;99(11):7616-21. doi: 10.1073/pnas.102650199.
(10) Genistein, Estrogen Receptors, and the Acquired Immune Response.The Journal of Nutrition, Volume 136, Issue 3, March 2006, Pages 704–708
(11) A Mixed Flavonoid-Fish Oil Supplement Induces Immune-Enhancing and Anti-Inflammatory Transcriptomic Changes - A Randomized Controlled Trial. Nutrients. 2016 May; 8(5): 277.
(12) Synergistic attenuation of ovariectomy-induced bone loss by combined use of fish oil and 17β-oestradiol12Br J Nutr. 2017 Feb;117(4):479-489.
(13) Perspective: Estrogen and the Risk of cognitive Decline: A Missing Choline(rgic) Link? Advances in Nutrition, Volume 13, Issue 2, March 2022, Pages 376–387
(14) Liquiritigenin ameliorates memory and cognitive impairment through cholinergic. Arch Pharm Res. 2017 Oct;40(10):1209-1217. doi: 10.1007/s12272-017-0954-6.

Media Contact

H.R. Momayez Zadeh, Caribbean Venture Capital Corp., 1 3059880767, [email protected]

SOURCE H.R. Momayez Zadeh

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.